RVL Pharmaceuticals plc Capitalized Contract Cost, Net
RVL Pharmaceuticals plc had Capitalized Contract Cost, Net of $0 as of 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Assets
us-gaap:CapitalizedContractCostNet · last filed 2022-03-30
- 2021-12-31: Capitalized Contract Cost, Net $0.00.
- 2021-09-30: Capitalized Contract Cost, Net $0.00.
- 2021-06-30: Capitalized Contract Cost, Net $0.00.
- 2021-03-31: Capitalized Contract Cost, Net $0.00.
| Period end | Capitalized Contract Cost, Net |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 |
| 2020-12-31 | $0.00 8-K · filed 2021-09-08 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-11 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-19 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 8-K · filed 2019-12-20 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 |